XMMO - Invesco S&P MidCap Momentum ETF
| Assets | $931.43M |
| NAV | $84.14 |
| Expense Ratio | 0.34% |
| PE Ratio | 32.88 |
| Beta (5Y) | 1.02 |
| Dividend (ttm) | $0.34 |
| Dividend Yield | 0.40% |
| Ex-Dividend Date | Mar 22, 2021 |
| 1-Year Return | - |
| Trading Day | April 20 |
| Last Price | $84.14 |
| Previous Close | $85.40 |
| Change ($) | -1.26 |
| Change (%) | -1.48% |
| Day's Open | 85.37 |
| Day's Range | 83.27 - 85.67 |
| Day's Volume | 36,767 |
| 52-Week Range | 49.71 - 88.97 |
Fund Description
The investment seeks to track the investment results (before fees and expenses) of the S&P MidCap 400® Momentum Index (the underlying index). The fund generally will invest at least 90% of its total assets in the securities that comprise the underlying index. Strictly in accordance with its guidelines and mandated procedures, the index provider compiles, maintains and calculates the underlying index, which is composed of constituents of the S&P MidCap 400® Index that have the highest momentum score.
| Asset Class Equity | Sector Mid Cap |
| Region North America | Inception Date Mar 3, 2005 |
| Exchange NYSEARCA | Ticker Symbol XMMO |
| Index Tracked S&P Midcap 400 Momentum Index | |
Top 10 Holdings
28.94% of assets| Name | Symbol | Weight |
|---|---|---|
| SolarEdge Technologies | SEDG | 3.56% |
| Boston Beer Company | SAM | 3.34% |
| Darling Ingredients | DAR | 3.17% |
| Bio-Techne | TECH | 3.01% |
| Charles River Laboratories | CRL | 2.92% |
| Molina Healthcare | MOH | 2.69% |
| Repligen | RGEN | 2.65% |
| Cree, Inc. | CREE | 2.60% |
| Lithia Motors | LAD | 2.56% |
| Cognex | CGNX | 2.44% |
Dividends
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Mar 22, 2021 | $0.05 | Mar 31, 2021 |
| Dec 21, 2020 | $0.039 | Dec 31, 2020 |
| Sep 21, 2020 | $0.158 | Sep 30, 2020 |
| Jun 22, 2020 | $0.093 | Jun 30, 2020 |
| Mar 23, 2020 | $0.185 | Mar 31, 2020 |
| Dec 23, 2019 | $0.171 | Dec 31, 2019 |
Here we highlight some momentum ETFs that are lucrative investment picks given the current market optimism.
Here we highlight some momentum ETFs that are lucrative investment picks now on the flowing in of positive news regarding coronavirus vaccine.
Here we highlight the reasons that make momentum ETFs lucrative investment picks now.
Here we discuss whether it will be wise to invest in momentum ETFs now as the U.S. manufacturing is showing signs of recovery along with improvements in the job market.
Here we discuss whether it will be wise to invest in momentum ETFs now as the U.S. manufacturing is showing signs of recovery along with improvements in the jobs market.
Here we discuss whether the market conditions are more conducive to investing in momentum ETFs.
A few positive developments on the vaccine front, unprecedented economic help, reopening of economies and a few bullish economic datapoints should facilitate momentum ETFs ahead.
Momentum investing would be a winning strategy for those seeking higher returns in a short spell.
We discuss some momentum ETFs, poised to benefit from the solid performance of major U.S. bourses.
